# S1B Testing for Carcinogenicity of Pharmaceuticals - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/s1b-testing-for-carcinogenicity-of-pharmaceuticals/8cc92fb9-6b17-465b-8cf3-ba1e865720dd

> FDA guidance document: S1B Testing for Carcinogenicity of Pharmaceuticals. Issue date: February 23, 1998. Get complete insights and analysis.

---

## Details

- Title: S1B Testing for Carcinogenicity of Pharmaceuticals
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1998-02-23
- Last Changed: 2020-04-17
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1996-D-0010">FDA-1996-D-0010</a>

## Related Documents

- [S2B Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/s2b-genotoxicity-a-standard-battery-for-genotoxicity-testing-of-pharmaceuticals/39dc5532-49cc-4723-ab60-cea50fce93fd)
- [Q1B Photostability Testing of New Drug Substances and Products](https://www.globalkeysolutions.net/guidances/guidance-document/q1b-photostability-testing-of-new-drug-substances-and-products/e6b04732-10d6-4998-b8d0-6dff64f41474)
- [S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/s6-preclinical-safety-evaluation-of-biotechnology-derived-pharmaceuticals/b4092e3c-509e-4d7e-9f1c-4d7274985cc7)